Venture Certified
| 혁신성장유형 | 2024-03-13 ~ 2027-03-12 | 20240313030055 | 2024-03-13 |
Revenue CAGR +135.1%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.7B | 0.0B | 0.1B |
| Operating Profit | -0.0B | -0.4B | -0.1B |
| Net Profit | -0.0B | -0.4B | -0.1B |
| Total Assets | 2.1B | 2.1B | 2.1B |
| Total Liabilities | 2.1B | 2.3B | 2.0B |
| Total Equity | 0.0B | -0.3B | 0.1B |
Capital Erosion: Total equity is negative or below 50% of capital stock
Debt Ratio 6035.4%: Exceeds 400%, financial soundness risk
Operating Loss: Op. profit -7310K
3 Consecutive Years of Net Loss
▲ 1005.2%
▲ 96.7%
▲ 98.3%
▲ 1589.8%
▼ 179.6%
| Name | Position | Role |
|---|---|---|
| 한영만 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "대전광역시 유성구",
"ceo_name": "한영만",
"certificate": [
{
"cert_number": "20240313030055",
"changes": "소재지",
"disclosure_date": "2024-03-13",
"first_cert_date": "2024-03-13",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2024-03-13 ~ 2027-03-12"
}
],
"company_name": "(주)아이단바이오",
"corp_no": "160111-*******",
"financials": {
"2022": {
"capital_stock": 20000000,
"cost_of_sales": 0,
"current_assets": 214992000,
"current_liabilities": 2542000,
"gross_profit": 12667000,
"net_income": -7550000,
"net_income_bs": -7550000,
"non_current_assets": 0,
"non_current_liabilities": 200000000,
"non_operating_expenses": 0,
"non_operating_income": 9000,
"operating_profit": -7559000,
"revenue": 12667000,
"sga_expenses": 20226000,
"total_assets": 214992000,
"total_equity": 12450000,
"total_liabilities": 202542000
},
"2023": {
"capital_stock": 20000000,
"cost_of_sales": 0,
"current_assets": 121936000,
"current_liabilities": 31792000,
"gross_profit": 0,
"net_income": -37853000,
"net_income_bs": -37853000,
"non_current_assets": 84454000,
"non_current_liabilities": 200000000,
"non_operating_expenses": 47534000,
"non_operating_income": 45869000,
"operating_profit": -36188000,
"revenue": 0,
"sga_expenses": 36188000,
"total_assets": 206390000,
"total_equity": -25402000,
"total_liabilities": 231792000
},
"2024": {
"capital_stock": 50000000,
"cost_of_sales": 0,
"current_assets": 47982000,
"current_liabilities": 5323000,
"gross_profit": 70000000,
"net_income": -1196000,
"net_income_bs": -1196000,
"non_current_assets": 160743000,
"non_current_liabilities": 200000000,
"non_operating_expenses": 4846000,
"non_operating_income": 4380000,
"operating_profit": -730000,
"revenue": 70000000,
"sga_expenses": 70730000,
"total_assets": 208725000,
"total_equity": 3402000,
"total_liabilities": 205323000
}
},
"industry": "자연과학 및 공학 융합 연구개발업",
"investment": [],
"main_products": "인공지능 플랫폼",
"phone": "010-9455-****",
"years": [
2024,
2023,
2022
]
}Data Quality: 8/10 | Primary Source: Venture System | Section Coverage: 7/8
| Section | Source: | Status |
|---|---|---|
| Basic Info | Public Data | Collected |
| Financial Statements | Venture System | Collected |
| Investment Metrics | Venture System | Collected |
| Officers | Public Data | Collected |
| Employment | Not Collected | Not Collected |
| Certifications | Public Data | Collected |
| Patents | KIPRIS | Collected |
| Procurement | G2B Procurement | Collected |
| API | Collected | Status |
|---|---|---|
| G2B Procurement | 2026-02-25 | Collected |
| KIPRIS Patents | 2026-02-25 | Collected |
| Employment Insurance | 2026-02-25 | Collected |
| HomeTax Business | 2026-02-25 | Collected |
| Cert. Info | 2026-02-25 | Collected |
| Venture System Detail | 2026-02-25 | Collected |